IgA nephropathy major breakthrough in the national scientific and technological progress in 2016 the first prize

IgA nephropathy major breakthrough in the national scientific and technological progress in 2016 the first prize
Recently, the CPC Central Committee and the State Council held a grand prize at the Great Hall of the People in Beijing. The party and leaders at all levels attended the congress and presented awards to the delegates who won the National Science and Technology Progress Award.
It is reported that the National Science and Technology Progress Award in 2016 a total of 171 awards results, including the Grand Prize 2, first prize 20 (including innovation team 3), 149 second prize. Among them, the Chinese Academy of Engineering led by Academician Chen Xiangmei, the Chinese People's Liberation Army General Hospital and the Soviet Union in the pharmaceutical industry and other units jointly completed the "IgA nephropathy syndrome treatment and diagnosis and treatment of key technology research and application" project, access to national scientific and technological progress Award first prize.
The project will integrate the holistic view of TCM into the clinical practice of western medicine, reveal the new mechanism of IgA nephropathy from the perspective of integrated traditional Chinese and western medicine, and successfully establish a new scheme for the treatment of IgA nephropathy by combining traditional Chinese and western medicine. The academic value and social and economic benefits are recognized by both domestic and foreign countries. . It is worth noting that the research results embodies the core value of Suzhong Pharmaceutical Huangshuhua preparation, which is a model of collaborative innovation, hospital-enterprise cooperation, and truly industrialized and market-oriented development of scientific and technological achievements.
This is a clinical study of kidney disease is another major breakthrough in the Soviet Union is a major progress in the pharmaceutical industry.
Su Chinese medicine in the Abelmoschus flower preparation, "Abalone" for the unilateral development of successful patented products, the national health insurance varieties. Indications: edema, low back pain, proteinuria, hematuria, yellow greasy tongue coating and so on.
According to "Compendium of Materia Medica" records, Abelmoschus odor, cold, slippery, non-toxic, attending urinary leaching and birth, cure all evil sore pus for a long time not those who apply for the end of the deposited that is more , For the sores to drugs, eliminate gangrene swelling, immersion oil Tu Tang fire and so on. In modern medicine, the main active component of abelmoschus is flavonoids, with the protection of podocytes, anti-inflammatory, anti-fibrosis, anti-oxidation, reduce immune complex deposition and other pharmacological effects, related research published in "Journal of Ethnopharmacology" , "Chinese Journal of kidney disease" and other core journals.
Based on its pharmacological effects, then, abercrombie and fitch, abercrombie and fitch, abercrombie and fitch sale, abercrombie and fitch,
Led by Chen Xiangmei, "Huang Kwai treatment of primary glomerular disease efficacy and safety of clinical studies," the results showed that 414 cases of CKD patients after 24 weeks of treatment, Huang Kwai group 24 h urinary protein reduction rate was significantly better than los Tan, and high security, long-term use. The study, published in the "Am J Kidney Dis", is a higher level of evidence of kidney medicine proprietary Chinese medicine evidence.
In order to accumulate more evidence-based medical evidence, Chen Xiangmei Academy of Sciences in conjunction with the Soviet Union make persistent efforts to start the "treatment of chronic kidney disease drug Huangkuang IV clinical study." In accordance with international standards, 106 top three hospitals, 4000 subjects to participate, is a proprietary Chinese medicine treatment of chronic kidney disease large-scale randomized controlled study. The project was recognized by the state, selected countries, "second five" science and technology to create major new drug projects.
In addition, the Soviet Union active in the pharmaceutical industry with international practice, is currently working with France, "Huang Kwai treatment of diabetic nephropathy proteinuria clinical study", the French government approved the international cooperation projects of Chinese medicine. Huang Kwai is a self-confident grace to challenge the world!
Absuria flower preparations are walking in their own evidence-based medicine on the road, confident and firm. It will lead the kidney medicine first to achieve modernization and internationalization.
In addition, it is understood that the Soviet Union in the pharmaceutical industry as the lead unit of this project, as early as 2000, began to select the best source of Anthurium to determine the provenance of Abelmoschus. Only the seeds, the Soviet Union on the medicine industry won five patents, to protect the accumulation of technology over the years. Also spent tens of millions to build GAP planting base of Abelmoschus, in order to ensure consistency, product uniformity, safety and controllability.
All along, the Soviet Union in the pharmaceutical industry has developed higher than the national standard enterprise standards, to achieve a standardized process quality management, quality control anytime, anywhere to form a "whole process of quality control, digital information storage" to ensure safe and efficient products!
"Science and technology to create health" is the Soviet Union in the pharmaceutical industry has been advocating the spirit of enterprise. In five thousand years of continuous clinical validation of Chinese medicine formulations, the Soviet Union in the pharmaceutical industry adhere to independent innovation, a substantial increase in R & D investment, the establishment of post-doctoral workstations, academicians workstation and provincial technical centers, and the Chinese Academy of Social Sciences in close cooperation with science and technology As the guide, strengthen the scientific and technological content of products, the successful development of more than three national patents 16 new drugs.
To lead the development of innovation, innovation advantage to win competitive advantage. Su established a combination of production and research innovation system, to achieve rely on scientific and technological innovation to adjust the industrial structure, promote industrial optimization and upgrading, and vigorously promote the industrialization of major scientific and technological achievements, so that scientific and technological innovation to truly promote the development of the Soviet Union in the pharmaceutical industry, the main productive forces .
Su in the pharmaceutical industry to participate in the study, and won the National Science and Technology Progress Award, is the Soviet Union in the pharmaceutical research and innovation of a recognition and encouragement. The project will further accelerate the transformation of medical research results into the Soviet Union in the pharmaceutical industry a new economic growth point, but also for patients with IgA nephropathy drugs provide a better choice and create greater social benefits.
The future, the Soviet Union in the medicine industry will make full use of its human resources, product development and market development of the comprehensive advantages, the introduction of talent, the introduction of the project, the introduction of funds to promote modernization of Chinese medicine, internationalization, the benefit of more people!